Kintsugi

Kintsugi Uses Machine Learning and Voice Biomarkers to Detect Clinical Depression and Anxiety. It Provides Talk Therapy Software to Users in Over 250 International Cities and Has Created the First Clinical-Grade Voice Biomarker Diagnostic Product (Patent Pending and FDA De Novo Application in the U.S.) by Collecting the World’s Largest Longitudinal, Annotated Machine Learning Voice Dataset to Measure the Severity of Depression and Anxiety in Real Time.